Sökning: onr:"swepub:oai:DiVA.org:uu-108589" > Synthesis and chara...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04067naa a2200505 4500 | |
001 | oai:DiVA.org:uu-108589 | |
003 | SwePub | |
008 | 090923s2011 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-1085892 URI |
024 | 7 | a https://doi.org/10.1002/jlcr.19092 DOI |
040 | a (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Blom, Elisabethu Uppsala universitet,Institutionen för biokemi och organisk kemi,Bengt Långström4 aut0 (Swepub:uu)elblo622 |
245 | 1 0 | a Synthesis and characterization of scVEGF-PEG-[68Ga]NOTA and scVEGF-PEG-[68Ga]DOTA PET tracers |
264 | c 2011-08-08 | |
264 | 1 | b Wiley,c 2011 |
338 | a print2 rdacarrier | |
520 | a Vascular endothelial growth factor (VEGF) signaling via vascular endothelial growth factor receptor 2 (VEGFR-2) on tumor endothelial cells is a critical driver of tumor angiogenesis. Novel anti-angiogenic drugs target VEGF/VEGFR-2 signaling and induce changes in VEGFR-2 prevalence. To monitor VEGFR-2 prevalence in the course of treatment, we are evaluating (68)Ga positron emission tomography imaging agents based on macrocyclic chelators, site-specifically conjugated via polyethylene glycol (PEG) linkers to engineered VEGFR-2 ligand, single-chain (sc) VEGF. The (68)Ga-labeling was performed at room temperature with NOTA (2,2', 2 ''-(1,4,7-triazonane-1,4,7-triyl) triacetic acid) conjugates or at 90 degrees C by using either conventional or microwave heating with NOTA and DOTA (2,2', 2 '', 2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl) tetraacetic acid) conjugates. The fastest (similar to 2min) and the highest incorporation (>90%) of (68)Ga into conjugate that resulted in the highest specific radioactivity (similar to 400MBq/nmol) was obtained with microwave heating of the conjugates. The bioactivity of the NOTA-and DOTA-containing tracers was validated in 3-D tissue culture model of 293/KDR cells engineered to express high levels of VEGFR-2. The NOTA-containing tracer also displayed a rapid accumulation (similar to 20s after intravenous injection) to steady-state level in xenograft tumor models. A combination of high specific radioactivity and maintenance of functional activity suggests that scVEGF-PEG-[(68)Ga] NOTA and scVEGF-PEG-[(68)Ga] DOTA might be promising tracers for monitoring VEGFR-2 prevalence and should be further explored. | |
650 | 7 | a NATURVETENSKAPx Kemix Organisk kemi0 (SwePub)104052 hsv//swe |
650 | 7 | a NATURAL SCIENCESx Chemical Sciencesx Organic Chemistry0 (SwePub)104052 hsv//eng |
650 | 7 | a TEKNIK OCH TEKNOLOGIERx Medicinteknikx Medicinsk bildbehandling0 (SwePub)206032 hsv//swe |
650 | 7 | a ENGINEERING AND TECHNOLOGYx Medical Engineeringx Medical Image Processing0 (SwePub)206032 hsv//eng |
653 | a scVEGF | |
653 | a (68)Ga | |
653 | a radiolabeling | |
653 | a angiogenesis | |
653 | a VEGFR-2 | |
653 | a PET | |
700 | 1 | a Velikyan, Irinau Uppsala universitet,Enheten för biomedicinsk strålningsvetenskap4 aut0 (Swepub:uu)irinveli |
700 | 1 | a Monazzam, Azitau Uppsala universitet,Endokrin tumörbiologi4 aut0 (Swepub:uu)azmon677 |
700 | 1 | a Razifar, Pashau Uppsala universitet,Centrum för bildanalys,Bildanalys och människa-datorinteraktion4 aut0 (Swepub:uu)serra226 |
700 | 1 | a Nair, Manoj4 aut |
700 | 1 | a Razifar, Payam4 aut |
700 | 1 | a Vanderheyden, Jean-Luc4 aut |
700 | 1 | a Krivoshein, Arcadius V.4 aut |
700 | 1 | a Backer, Marina4 aut |
700 | 1 | a Backer, Joseph4 aut |
700 | 1 | a Långström, Bengtu Uppsala universitet,Institutionen för biokemi och organisk kemi4 aut0 (Swepub:uu)benglang |
710 | 2 | a Uppsala universitetb Institutionen för biokemi och organisk kemi4 org |
773 | 0 | t Journal of labelled compounds & radiopharmaceuticalsd : Wileyg 54:11, s. 685-692q 54:11<685-692x 0362-4803x 1099-1344 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-108589 |
856 | 4 8 | u https://doi.org/10.1002/jlcr.1909 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy